A comprehensive view of Approved Drugs / Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AbbVie gains European Commission approval for SKYRIZI® to treat moderate to severe ulcerative colitis in adults; supported by two pivotal Phase 3 trials showing clinical remission
Published: July 26, 2024 by AbbVie Inc.
European Commission approves Pfizer's DURVEQTIX® gene therapy for hemophilia B; reduces bleeds post-treatment with a median annualized bleed rate of zero bleeds after up to four years of follow-up
Published: July 25, 2024 by Pfizer Inc.
GlobalData: FDA approves OTC continuous glucose monitors from Dexcom and Abbott, designed for individuals who don't use insulin; high prediabetes prevalence expected to drive global market of OTC CGMs to reach US$5.1B by 2033
Published: July 23, 2024 by GlobalData Plc
Johnson & Johnson seeks FDA approval for depression nasal spray monotherapy; J&J aims to expand Spravato's indication for treatment-resistant depression in adults
Published: July 22, 2024 by FiercePharma
Roche's Susvimo shows sustained efficacy over two years in Phase III diabetic eye studies; FDA accepts application for diabetic macular edema and retinopathy treatments based on one-year results
Published: July 18, 2024 by F. Hoffmann-La Roche Ltd. (Roche)

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count